SMALL LYMPHOCYTIC LEUKEMIA (SLL)
Clinical trials for SMALL LYMPHOCYTIC LEUKEMIA (SLL) explained in plain language.
Never miss a new study
Get alerted when new SMALL LYMPHOCYTIC LEUKEMIA (SLL) trials appear
Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LEUKEMIA (SLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail tested to fight returning blood cancer
Disease control Recruiting nowThis study is testing whether a combination of three drugs—pirtobrutinib, venetoclax, and obinutuzumab—can help control chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back after previous treatment. The treatment is given for a limited time, n…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA (SLL)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Triple-Drug attack aims to wipe out CLL and SLL
Disease control Recruiting nowThis study tests whether a combination of three drugs (zanubrutinib, obinutuzumab, and venetoclax) can make chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) undetectable in the body. About 230 adults who have not had prior treatment for these blood cancers w…
Matched conditions: SMALL LYMPHOCYTIC LEUKEMIA (SLL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC